232 related articles for article (PubMed ID: 28064104)
21. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Mahato RI; Cheng K; Guntaka RV
Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
[TBL] [Abstract][Full Text] [Related]
22. Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery.
Margus H; Padari K; Pooga M
Mol Ther; 2012 Mar; 20(3):525-33. PubMed ID: 22233581
[TBL] [Abstract][Full Text] [Related]
23. Targeting Therapeutic Oligonucleotides.
Levin AA
N Engl J Med; 2017 Jan; 376(1):86-88. PubMed ID: 28052219
[No Abstract] [Full Text] [Related]
24. Peptide vectors for the nonviral delivery of nucleic acids.
Hoyer J; Neundorf I
Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
[TBL] [Abstract][Full Text] [Related]
25. Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology.
Lin W; Cormier M; Samiee A; Griffin A; Johnson B; Teng CL; Hardee GE; Daddona PE
Pharm Res; 2001 Dec; 18(12):1789-93. PubMed ID: 11785702
[No Abstract] [Full Text] [Related]
26. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.
Kolli CS; Xiao J; Parsons DL; Babu RJ
Drug Dev Ind Pharm; 2012 May; 38(5):571-6. PubMed ID: 21980925
[TBL] [Abstract][Full Text] [Related]
27. Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis.
Tomoda K; Watanabe A; Suzuki K; Inagi T; Terada H; Makino K
Colloids Surf B Biointerfaces; 2012 Sep; 97():84-9. PubMed ID: 22609586
[TBL] [Abstract][Full Text] [Related]
28. Lipid conjugated oligonucleotides: a useful strategy for delivery.
Raouane M; Desmaële D; Urbinati G; Massaad-Massade L; Couvreur P
Bioconjug Chem; 2012 Jun; 23(6):1091-104. PubMed ID: 22372953
[TBL] [Abstract][Full Text] [Related]
29. Nucleic acid-based techniques for post-transcriptional regulation of molecular targets.
Jarad G; Simske JS; Sedor JR; Schelling JR
Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):415-21. PubMed ID: 12815338
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells.
Miyagishi M; Hayashi M; Taira K
Antisense Nucleic Acid Drug Dev; 2003 Feb; 13(1):1-7. PubMed ID: 12691531
[TBL] [Abstract][Full Text] [Related]
31. RNAi: a novel antisense technology and its therapeutic potential.
Dallas A; Vlassov AV
Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063
[TBL] [Abstract][Full Text] [Related]
32. Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo.
Tomoda K; Terashima H; Suzuki K; Inagi T; Terada H; Makino K
Colloids Surf B Biointerfaces; 2012 Apr; 92():50-4. PubMed ID: 22154100
[TBL] [Abstract][Full Text] [Related]
33. Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs.
Johannes L; Lucchino M
Nucleic Acid Ther; 2018 Jun; 28(3):178-193. PubMed ID: 29883296
[TBL] [Abstract][Full Text] [Related]
34. Transdermal iontophoretic delivery of propofol: a general anaesthetic in the form of its phosphate salt.
Juluri A; Peddikotla P; Repka MA; Murthy SN
J Pharm Sci; 2013 Feb; 102(2):500-7. PubMed ID: 23175436
[TBL] [Abstract][Full Text] [Related]
35. Transdermal delivery of phosphorodiamidate Morpholino oligomers across hairless mouse skin.
Pannier AK; Arora V; Iversen PL; Brand RM
Int J Pharm; 2004 May; 275(1-2):217-26. PubMed ID: 15081152
[TBL] [Abstract][Full Text] [Related]
36. [Oligonucleotide therapeutics - an emerging novel class of compounds].
Wacheck V
Wien Med Wochenschr; 2006 Sep; 156(17-18):481-7. PubMed ID: 17041803
[TBL] [Abstract][Full Text] [Related]
37. Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin.
Oldenburg KR; Vo KT; Smith GA; Selick HE
J Pharm Sci; 1995 Aug; 84(8):915-21. PubMed ID: 7500273
[TBL] [Abstract][Full Text] [Related]
38. Topical delivery of anti-sense oligonucleotides using low-frequency sonophoresis.
Tezel A; Dokka S; Kelly S; Hardee GE; Mitragotri S
Pharm Res; 2004 Dec; 21(12):2219-25. PubMed ID: 15648253
[TBL] [Abstract][Full Text] [Related]
39. Transdermal delivery of antisense oligonucleotides can induce changes in gene expression in vivo.
Brand RM; Hannah TL; Norris J; Iversen PL
Antisense Nucleic Acid Drug Dev; 2001 Feb; 11(1):1-6. PubMed ID: 11258617
[TBL] [Abstract][Full Text] [Related]
40. Effects of size and sequence on the iontophoretic delivery of oligonucleotides.
Brand RM; Wahl A; Iversen PL
J Pharm Sci; 1998 Jan; 87(1):49-52. PubMed ID: 9452967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
